International Journal of Pharma and Bio Sciences STANDARDIZATION OF ELISA AS A TEST FOR ESTIMATION OF ASVS IN EQUINE SERA

Similar documents
Materials and Methods: Anti-snake venom activities of Asparagus racernosus

TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS

Sera from 2,500 animals from three different groups were analysed:

Neutralization of Micrurus distans distans venom by antivenin (Micrurus fulvius)

5 Dangerous Venom Types Thailand Snakes. Thailand Snake Venom Types:

Venom Research at Natural Toxins Research Center (NTRC)

DETECTION AND NEUTRALIZATION OF VENOM BY OVINE ANTISERUM IN EXPERIMENTAL ENVENOMING BY Bothrops jararaca

DOWNLOAD OR READ : SNAKE BITE PDF EBOOK EPUB MOBI

Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain

SNABIRC-KENYA A GUIDE TO MANAGING SNAKEBITES

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

VENOMS OF CORAL SNAKES (MICRURUS SPP.): REPORT ON A MULTIVALENT ANTIVENIN FOR THE AMERICAS

(D) fertilization of eggs immediately after egg laying

Antibody Test Kit for Feline Calici, Herpes and Panleukopenia Viruses (2011)

SNAKE ENVENOMATION. RYAN DE VOE DVM, MSpVM, DACZM, DABVP-Avian. Modified by Michael R.Loomis, DVM, MA, DACZM North Carolina Zoological Park

6/20/2018. A Public Benefit Corporation. A First-in-Class Snakebite Antidote. Discovery to Accelerated Development

. Analgesics and antipyretics (tabkt mefanemic acid

Bovine Brucellosis Control of indirect ELISA kits

Toxocariasis: serological diagnosis by enzyme

Title. Author(s)WANG, Chun-Tshen. CitationJapanese Journal of Veterinary Research, 39(2-4): 10. Issue Date DOI. Doc URL.

Traveling Treasures 2016 The Power of Poison

Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infectionindogs

WHO/SEARO GUIDELINES FOR THE CLINICAL MANAGEMENT OF SNAKE BITES IN THE SOUTHEAST ASIAN REGION

Clinical Profile of Envenomation in Children With Reference To Snake Bite

NOTES IMMUNOGENICITY IN MONKEYS OF A COMBINED TOXOID FROM THE MAIN TOXIC PRINCIPLES SEPARATED FROM HABU SNAKE VENOM

UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES

ON HABU SNAKE VENOM 1. COMPARISON OF SEVERAL BIOLOGICAL ACTIVITIES OF FRESH AND DRIED HABU SNAKE VENOM

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

On the immunity of snakes to their own venom and to the venom of conspecifics across ontogeny

Malayan Pit Viper Venomous Very Dangerous

Fluoroquinolones ELISA KIT

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

Surveillance of Brucella Antibodies in Camels of the Eastern Region of Abu Dhabi, United Arab Emirates

Demographics of animal bite victims & management practices in a tertiary care institute in Mumbai, Maharashtra, India

By the end of this lecture students will be able to understand Importance, epidemiology, pathogenesis of snake bite Clinical manifestations

Antitoxin l.evels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and E

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Enzyme immunoassay for the qualitative determination of antibodies against Toxocara canis in human serum or plasma

Mojave rattlesnake envenomation in southern California: A review of suspected cases

Snake bites in north east Sri Lanka

VETERINARY PRODUCT REGISTRATION

Scientific Discussion post-authorisation update for Rheumocam extension X/007

INFECTIOUS HEPATITIS, PARVOVIRUS & DISTEMPER

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

Maharashtra, India. snake venom poisoning for animal experiment. The root of Vitex trifolia is

GUIDE TO THE PROFESSIONAL PRACTICE STANDARD

Just where it s needed.

Last Name First Name Middle Initial. UNL ID # Date of Birth Today s Date. Department: Cost Center #: Facility:

European Public MRL assessment report (EPMAR)

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Small Animal Medicine Paper 1

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.

Summary of product characteristics As per Annex C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

Surveillance of animal brucellosis

Supporting Online Material for

Pain management: making the most of the latest options

Clinical Features, Management and Outcome of Snake Bite in Children in Manipal Teaching Hospital

EUROPEAN REFERENCE LABORATORY (EU-RL) FOR BOVINE TUBERCULOSIS WORK-PROGRAMME PROPOSAL Version 2 VISAVET. Universidad Complutense de Madrid

Commonly Used Analgesics

Epidemiological profile of snake bite at tertiary care hospital, East India

Cattle Serologically Positive for Brucella abortus Have Antibodies

Domestic Bighorn Sheep Research American Sheep Industry/ National Lamb Feeders Association Annual Convention Charleston, SC January 22-25, 2014

Venomous Snakebite in Mountainous Terrain: Prevention and Management

New Insights into the Treatment of Leishmaniasis

ENZYME IMMUNOASSAYS FOR THE DIAGNOSIS OF BOVINE BRUCELLOSIS: TRIAL IN LATIN AMERICA

Standardisation of an indirect enzyme linked. of Brucella antibodies in milk from water buffalo

ELlSA Seropositivity for Toxocara canis Antibodies in Malaysia,

Bites in Australian snake handlers Australian snakebite project (ASP-15)

SUMMARY OF PRODUCT CHARACTERISTICS

ABSTRACT. The effect of exogenous oxytocin injected on different days of estrus cycle and pregnancy on uterine PGF 2a

Spiders and Snakes Martin Belson, MD

Rapid Diagnostic Test for pet

Evaluation of Different Antigens in Western Blotting Technique for the Diagnosis of Sheep Haemonchosis

Clostridial Vaccination Efficacy on Stimulating and Maintaining an Immune Response in Beef Cows and Calves 1,2

Received 27 November 1995/Returned for modification 14 March 1996/Accepted 8 April 1996

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

An objective approach to antivenom therapy and assessment of rst-aid measures in snake bite

COUNCIL REGULATION (EEC) No 2377/90

Immunoglobulin Subclass-Specific Response to Brucella

Summary of Product Characteristics

Overview and Expectations

Spider bite the redback spider and its relatives

VETERINARY MEDICINE-VM (VM)

Ecopel Corporation Limited is an affiliate of Celessence International Limited

ff2 REFJPORT: Final Report-~Vs ~

Regional vs Systemic Antivenom Administration in the Treatment of Snake Venom Poisoning in a Rabbit Model: A Pilot Study

An ELISA for the evaluation of gamma interferon. production in cattle vaccinated with Brucella abortus

IJBCP International Journal of Basic & Clinical Pharmacology

VENOM WEEK 2005 (Formerly "Snakebites in the New Millenium: A State-of-the-Art-Symposium" Friday, October 21, 2005: Field Trip, Introductions and

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Clostridium difficile Colitis

VENOMOUS SNAKE BITES IN LAO PDR: A RETROSPECTIVE STUDY OF 21 SNAKEBITE VICTIMS IN A PROVINCIAL HOSPITAL

The Most Venomous Dangerous Deadly Poisonous Snakes?

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

National Research Center

July/August Joe McDonald

2. Introduction. 2.1 Venomous snakes of Southeast Asia The venom apparatus (Fig 2) Classification

Transcription:

International Journal of Pharma and io Sciences RSRH RTIL IOTHNOLOGY STNRIZTION OF LIS S TST FOR STIMTION OF SVS IN QUIN SR orresponding uthor MUGSH SNKRNRYNN Veltech Hightech r Rangarajan r Sakunthala ngineering ollege, vadi, hennai, India. o uthors MUGSH SNKRNRYNN, VSUVN MURLIHRN, PRVN KUMR MUTHU, HNRN MSI, SIVRMN SLVRSU, JYRMN PLNIMUTHU N SKR U HRI RM Veltech Hightech r Rangarajan r Sakunthala ngineering ollege, vadi, hennai, India. STRT Snakebite is a serious medical problem worldwide especially in the tropics and subtropics. dministration of anti-snake venom serum (SVS) is the only effective treatment for snakebites. Snake venom is used to make antivenom serum from horse as the host. Several methods have been suggested as alternatives to the mouse bioassay for venom toxicity and to determine the potency of polyvalent anti-snake venom serum. The present study is done by using LIS as an alternative to animal assay in screening the equine sera for the presence of antibodies. In the present study, obra venom concentrations ranging from 1ng to 100ng / 100 µl / well were used initially for coating. From this 1ng of obra venom was found to be sufficiently enough for estimating SVS. SVS dilutions upto 1:128 were used and dilutions exceeding this range were found to have no detectable ntivenom. There was a reduction in the O. values when the coating time was reduced, but still the O. values between Neat and negative controls are discriminatory. This protocol if standardized will minimize the time duration of the test. - 101

KY WORS LIS, venom, nti-snake venom serum. ioassay, ntibodies INTROUTION Snake envenomation (considered as a subcutaneous or intradermal injection of venom into the prey or human victims) constitutes a medical hazard in most regions of the world. Snakebite is a serious medical problem worldwide especially in the tropics and subtropics. Snakebite is regarded as a significant medical problem in parts of sia and frica. Over the years many medications have been tried to treat snake bite victims (Robert Morris., 2002). Snake envenomation is complex involving the direct action of venom components on the tissue and release of various endogenous mediators. Snake venoms are known to cause different metabolic disorders by altering the cellular and enzymatic activities in animals. (.V.Lipps., 1999). The neurotoxin of cobra venom blocks nerve transmission at the site of the neuromuscular junction. (Su J., 1960).Neurotoxin exerts their toxicity by binding to the acetylcholine receptor (chr) and block neuromuscular transmission. (Lee et al., 1972). In addition to neurotoxins, snake venom from cobras usually contains another group small basic protein called cardiotoxin or cytotoxin. espite their different modes of pharmacological action, neurotoxins and cardiotoxins share a high degree of homology (ook-venoms). SVS is produced from healthy horses. Nonlethal dose of venom is injected intramuscularly. The dose of venom is increased and administered over a period of time to enhance immunity. The horse serum, which contains antibodies to the venom, is harvested and concentrated. (Gutieruz et al., 1989). dministration of anti-snake venom serum (SVS) is the only effective treatment for snakebites. History of SVS dates back to1987. Snake venom is used to make antivenom serum from horse as the host. The use of LIS to determine antisnake venom potency of horse immune sera should provide benefits of costs and reproducibility compared to in vivo assays. For the indirect LIS method, 0.016 micrograms/well of othrops jararaca or rotalus durissus terrificus venom were used to coat the plates and 100 microliters/well of each sample of antibothropic or anticrotalic venom sera were used at 1:10,000 dilution. (arbosa F, Rodrigues RJ, Olortegui, Sanchez F, Heneine LG., 1995). Potency of SVS has been tested by using immunodiffusion, passive haemagglutination, counter current immuno electrophoresis and Radio immunoassay (RI). None of these methods was totally satisfactory for use in tropical countries where snakebites are a major public health problem due to their cost, insensitivity or instability of reagents. LIS [Selvanayagam Z. et al.(1999). helps in the differential diagnosis of patients bitten by snakes of different species, which can produce similar clinical features. Refined LIS techniques have allowed the evaluation of the potency of antivenom. Therefore in the present study, use of LIS as an alternative to animal assay in screening the equine sera for the presence of antibodies was evaluated.the potency of horse therapeutic polyvalent antibothropic antivenom was assessed by LIS. They indicated that the fractions of purified antigens would be suitable for the invitro assay. (Heneine et al 1998). MTRILS N MTHOS - 102

Materials 1% obra venom was received from the epartment of ntitoxin (T), King Institute of Preventive Medicine hennai. Polyvalent SVS used for neutralization of cobra venom. Rabbit nti-horse IgG peroxidase conjugate (Product no. 6917) was obtained from SIGM-LRIH, Missouri, US. Nunc Immuno U16 maxisorp L-469264 strips were used for LIS. arbonate uffer (0.04 M),Phosphate uffered Saline (PS),PS- Tween solution locking solution (ovine serum lbumin 1%) Tetramethyl benzidine(tm) solution,stop solution (0.1M Phosphoric acid solution) were prepared using standard procedure Methods xperiment 1: - 103

100µl of various dilutions of SVS (Neat, 1: 2, 1: 4, 1:8, 1: 16, 1: 32) were added in duplicates. 1. 100µl of Neat SVS was added from 1 to 10. 2. 100µl of 1:2 dilutions of SVS was added from 1 to 10. 3. 100µl of 1:4 dilutions of SVS was added from 1 to 10. 4. 100µl of 1:8 dilutions of SVS was added from 1 to 10. 5. 100µl of 1:16 dilution of SVS was added from 1 to 10. 6. 100µl of 1:32 dilution of SVS was added from F1 to F10. 7. 100µl of substrate control was added from G1 to G10. 8. 100µl of negative control was added from H1 to H10. xperiment 2: U16 strips were coated with 1ng and 10ng of cobra venom in duplicates. Venom concentration: 1ng / 100µl & 10 ng / 100 µl of venom with carbonate buffer were coated from 1 to 2 & 3 to 4 respectively. xperiment 3: U16 strips were coated with 1ng of cobra venom in duplicates. Venom concentration: 1ng / 100µl of venom with carbonate buffer was coated from 1 to 2 xperiment 4 and 5: U16 strips were coated with 1ng of cobra venom in duplicates. Venom concentration: 1ng / 100µl of venom with carbonate buffer was coated from 1 to H2 as depicted in table 4. - 104

RSULTS etermination of SVS concentrations in various dilutions by LIS: 1ng, 10ng, 25ng, 50ng and 100ng Venom concentrations were used. Table: 1 etermination of SVS dilutions for various venom concentrations were carried out: Neat 1:2 1:4 1:8 1:16 F 1:32 G H N 1 ng 10ng 25 ng 50 ng 100 ng 1 2 3 4 5 6 7 8 9 10 0.560 0.561 0.750 0.748 0.849 0.847 0.745 0.747 0.725 0.723 0.543 0.545 0.721 0.720 0.813 0.811 0.698 0.696 0.682 0.683 0.507 0.509 0.686 0.683 0.776 0.776 0.632 0.635 0.617 0.620 0.481 0.483 0.641 0.645 0.745 0.748 0.601 0.600 0.591 0.593 0.463 0.462 0.617 0.618 0.709 0.712 0.579 0.580 0.565 0.563 0.441 0.443 0.594 0.597 0.691 0.689 0.550 0.552 0.531 0.534 0.053 0.053 0.055 0.054 0.053 0.052 0.053 0.051 0.056 0.056 0.061 0.061 0.059 0.028 0.057 0.059 0.060 0.060 0.059 0.058 The above readings depict the Optical density values of xperiment 1, Where Neat, 1:1, 1:2, 1:4, 1:8, 1:16 and 1:32 of SVS dilutions were used. From the above Table it is inferred that as the dilutions of SVS increases the O. values decreases gradually. Though there is decrement, the differences in the titer values are not much. It is observed from above that 1ng of venom is able to give a very discriminatory O. value between the negative control and the neat. This shows that even 1ng of obra venom can be effectively used in detecting the potency of SVS. This economizes the use of venom in LIS. Table: 2 etermination of SVS concentrations for 1ng and 10ng of obra venom 1:32 1:64 1:128 N 1ng 10ng 1 2 3 4 0.445 0.447 0.591 0.589 0.421 0.423 0.563 0.561 0.401 0.404 0.537 0.539 0.053 0.051 0.054 0.051 0.057 0.056 0.058 0.057-105

The above readings depict the Optical density values of xperiment 2, Where 1:32, 1:64 and 1:128 of SVS dilutions were used against 1ng and 10ng of obra venom. The above table shows the same result as that of the first experiment. Here too the O. value decreases consistently with the increase in dilution of SVS. It is found that even 1:128 dilutions of SVS gave a detectable O. value. This shows that even 1ng of obra venom can be effectively used in detecting the potency of SVS. Table: 3 etermination of SVS concentrations for 1ng of obra venom 1:100 1:200 1:400 N 1ng 1 2 0.413 0.416 0.361 0.359 0.302 0.305 0.051 0.054 0.063 0.061 The above readings depict the Optical density values of xperiment 3, Where 1:100, 1:200 and 1:400 of SVS dilutions were used against 1ng of obra venom. The above table depicts that, as the dilutions exceed 1:200 the O. value decreases considerably. ilutions greater than this do not have detectable antivenom implying waning antibodies. Table: 4 etermination of SVS concentrations for 1ng of obra venom N Neat 1:8 1:16 F 1:32 G 1:64 H 1:128 1 ng 1 2 0.060 0.060 0.053 0.053 0.563 0.561 0.483 0.484 0.461 0.463 0.446 0.445 0.421 0.420 0.392 0.393-106

Table: 5 etermination of SVS concentrations for 1ng of obra venom N Neat 1:8 1:16 F 1:32 G 1:64 H 1:128 1 ng 1 2 0.060 0.060 0.053 0.056 0.565 0.562 0.486 0.484 0.461 0.463 0.445 0.445 0.423 0.420 0.391 0.390 The above readings depict the Optical density values of xperiments 4 & 5, Where Neat, 1:8, 1:16, 1:32, 1:64 and 1:128 of SVS dilutions were used against 1ng of obra venom. Reproducible results were obtained in the above two experiments with respect to various dilutions of SVS as evidenced by calculation of mean and standard deviation. U16 strips were coated with various concentrations of cobra venom in duplicates. IUSSION LIS for detection of SVS against cobra venom in equine sera is proved to be simple, sensitive and reproducible. LIS method is economical, as it requires minimum concentration of venom and ntivenom serum. LIS is rapid as the time taken for assessing the potency of SVS against obra venom is minimized. ilutions 1:1, 1:8, 1:16, 1:32, 1:64 and 1:128 of SVS showed antibodies against cobra venom. Further assessment of LIS has to be done to formulate the assay as a kit for routine use. ONLUSION Standardization of LIS as a test for estimation of SVS in the sera produced from Horses was carried out in the present study. obra venom concentrations ranging from 1ng to 100ng / 100 µl / well were used initially for coating. From this 1ng of obra venom was found to be sufficiently enough for estimating SVS. SVS dilutions upto 1:128 were used and dilutions exceeding this range were found to have no detectable ntivenom. ILIOGRPHY 1. Heineine L.G., arvalho.., arbosac F., ravjo ossantos M.F(1998), evelopment - 107

of an LIS to asses the potency of Horse therapeutic polyvalent antithropic antivenom. Toxicon. 36(10).1363-70. 2. Lee.Y., Lin L.S (1972)., Prog.Natl.Sci.coun.Vol 5.9. 3. Lipps.V. (1999), Novel snake venom proteins cytolytic to cancer cells invitro and invivo systems. J. Venom. nim. Toxins.5, 172-173. 4. Minton S. (1987). Present tests for detection of snake venom, clinical applications. nnual merging Medicine 16(9) 932-37. 5. Selvanayagam Z. et al. (1999). LIS for detection of venoms from four medically important snakes of India.Toxicon 37, 757 70 6. Stiles.G(1993), cetylcholine receptor binding characteristics of Snake and cone snail venom post synoptic neurotoxins further studies with a nonradioactive assay. Toxicon31 (7) 825=34. 7. Su.J (1960), Formosan. Med. ssocia. Vol 59, 1083. - 108